Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...
Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk ...
Published in Scientific Reports, new research provides evidence that minor compounds in psychedelic mushrooms work alongside ...
This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...
(Nasdaq: VCYT), a leading cancer diagnostics company, announced today that Kevin Haas, Ph.D., has been appointed Chief Development and Technology Officer, a newly created leadership role designed to ...
(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a managing advanced disease in renal ...
Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic ...
Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results